CF
government

China Structural Reform Fund

China

China Structural Reform Fund is a public investment body based in China, investing in Healthcare & Life Sciences, Oncology & Cancer Treatment and Pharmaceutical Development, 1 tracked investment.

1
Investments Tracked

About China Structural Reform Fund

Operating out of China, China Structural Reform Fund is a public investment body. Our dataset covers 1 investment involving China Structural Reform Fund.

Recorded deals span Healthcare & Life Sciences, Oncology & Cancer Treatment, Pharmaceutical Development and Pharma. Coverage extends to 8 sectors in total. Investments are concentrated at Series C+.

Invests in late-stage Healthcare & Life Sciences companies in China. Focuses on innovative therapeutics and technologies.

Investment Focus

Stage Focus
series-c-plus
Sectors
Healthcare & Life SciencesOncology & Cancer Treatmentpharmaceutical-developmentpharmar-dantibody-therapeuticsbiotechdrug-development

Investment Thesis

Invests in late-stage Healthcare & Life Sciences companies in China. Focuses on innovative therapeutics and technologies.

Explore China Structural Reform Fund's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in China

Other Investors in Healthcare & Life Sciences / Oncology & Cancer Treatment